Mar. 17 at 6:33 PM
$INO Sniper breakdown for the Oct 30 PDUFA. Here is the objective setup and why the current risk profile is elevated:
The Warrant Ceiling: Series A warrants were extended to March 31 with a
$1.75 strike. Over 13.5M shares are ready to be exercised, creating a massive technical ceiling on any retail volume.
Financial Pressure: Cash runway only lasts into Q4 2026. An offering is highly probable well before the Oct PDUFA to secure funding.
Regulatory and CMC Red Flags: Denied priority review in Dec. Now dealing with a new class action lawsuit over CELLECTRA device manufacturing issues. FDA scrutiny on combo product CMC is strict.
Bottom line: Solid science, but the financial and regulatory setup is complex. Keeping this on strict radar to see how the warrant and cash situations resolve before making a move.
